Concepedia

Thomas Spires

TS

17

Publications

1.2K

Citations

15

H-Index

2005

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Vall d'Hebron Hospital Universitari

Bristol-Myers Squibb (Sweden)

The University of Texas Southwestern Medical Center

Thomas Spires is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2005–2025

17

Publications

17

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

Solange Peters, Arnaud Scherpereel, Robin Cornelissen et al. · Annals of Oncology · 2022 · 250 citations · Full text

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Julio A. Chirinos, Alena Orlenko, Lei Zhao et al. · Journal of the American College of Cardiology · 2020 · 200 citations · Full text

, , +7

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Canan Kasikara, Viralkumar Davra, David Calianese et al. · Cancer Research · 2019 · 130 citations

The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens

Liang Schweizer, Cheryl A. Rizzo, Thomas Spires et al. · BMC Cell Biology · 2008 · 114 citations · Full text

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng et al. · Cancer Research · 2020 · 90 citations · Full text

Rows per page

1–5 of 17